Groundbreaking Data Demonstrate Superiority of EARLY TAVR in Asymptomatic Severe Aortic Stenosis Patients
Go back to Groundbreaking Data Demonstrate Superiority of EARLY TAVR in Asymptomatic Severe Aortic Stenosis Patients| Edwards Lifesciences (NYSE: EW) | Delayed: 86.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $86.95 | 52 Week High | $166.87 | |||
| Open | $86.95 | 52 Week Low | $72.20 | |||
| Day High | $86.95 | P/E | 25.28 | |||
| Day Low | $86.95 | EPS | $3.44 | |||
| Volume | 4 | |||||
